Innovation supporting the Chinese biopharmaceutical market
Avantor Shanghai, China
Innovation & Technology Center
The Avantor Shanghai Innovation & Technology Center was opened in 2019 as a technology-driven research and collaboration environment serving China and the broader AMEA region. Our teams of scientists and researchers collaborate with customers as well as Avantor’s extended teams to advance projects including:
- optimizing downstream process efficiency in the development of monoclonal antibodies
- and engineering next-generations of vaccines that improve global health.
Learn more about our capabilities and areas of focus in Shanghai.
Biopharma Process Development Support
- Chromatography process optimization (Capture, Intermediate, Polishing)
- Chromatography Life-cycle study
- Studies based on Design of Experiment
- Virus inactivation process support (Low pH, S/D treatment)
- Downstream Scale-up studies
- Support of virus clearance studies
- Documentation support (report, SOPs, MBR, tech transfer)
- Downstream Process Theory Training
- Downstream Process hands on training